Proteins are biopolymers of highly varied structures taking part in almost all processes
occurring in living cells. When nanoparticles (NPs) interact with proteins in biological …

The ever-growing use of inorganic nanoparticles (NPs) in biomedicine provides an exciting
approach to develop novel imaging and drug delivery systems, owing to the ease with which …

Micro-and nanoplastics (MNPs) are recognized as emerging contaminants, especially in
food, with unknown health significance. MNPs passing through the gastrointestinal tract …

Lipid-like nanoparticles (LNPs) have potential as non-viral delivery systems for mRNA
therapies. However, repeated administrations of LNPs may lead to accumulation of delivery …

In a perfect sequence of events, nanoparticles (NPs) are injected into the bloodstream
where they circulate until they reach the target tissue. The ligand on the NP surface …

Understanding nanoparticle–protein interactions is a crucial issue in the development of
targeted nanomaterial delivery. Besides unraveling the composition of the nanoparticle's …

Conspectus The use of nanoparticles (NPs) in biology and medicine requires a molecular-
level understanding of how NPs interact with cells in a physiological environment. A critical …

The current understanding of the biological identity that nanoparticles may acquire in a
given biological milieu is mostly inferred from the hard component of the protein corona …

Nanoparticles (NPs) are functionalized with targeting ligands to enable selectively delivering
drugs to desired locations in the body. When these functionalized NPs enter the blood …

The oral pathway is considered as the most common method for drug administration,
although many drugs, especially the highly pH-and/or enzymatic biodegradable peptide …